These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 25256353)

  • 41. Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.
    Takahashi Y; Uchino A; Shioya A; Sano T; Matsumoto C; Numata-Uematsu Y; Nagano S; Araki T; Murayama S; Saito Y
    Neuropathology; 2019 Aug; 39(4):268-278. PubMed ID: 31124187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.
    Ditsworth D; Maldonado M; McAlonis-Downes M; Sun S; Seelman A; Drenner K; Arnold E; Ling SC; Pizzo D; Ravits J; Cleveland DW; Da Cruz S
    Acta Neuropathol; 2017 Jun; 133(6):907-922. PubMed ID: 28357566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TARDBP pathogenic mutations increase cytoplasmic translocation of TDP-43 and cause reduction of endoplasmic reticulum Ca²⁺ signaling in motor neurons.
    Mutihac R; Alegre-Abarrategui J; Gordon D; Farrimond L; Yamasaki-Mann M; Talbot K; Wade-Martins R
    Neurobiol Dis; 2015 Mar; 75():64-77. PubMed ID: 25526708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.
    Braak H; Ludolph A; Thal DR; Del Tredici K
    Acta Neuropathol; 2010 Jul; 120(1):67-74. PubMed ID: 20379728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
    Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
    J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment.
    Martínez-González L; Rodríguez-Cueto C; Cabezudo D; Bartolomé F; Andrés-Benito P; Ferrer I; Gil C; Martín-Requero Á; Fernández-Ruiz J; Martínez A; de Lago E
    Sci Rep; 2020 Mar; 10(1):4449. PubMed ID: 32157143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis.
    Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.
    Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
    Kim HC; Zhang Y; King PH; Lu L
    J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
    Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
    Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Calpain plays a crucial role in TDP-43 pathology].
    Yamashita T; Kwak S
    Rinsho Shinkeigaku; 2014; 54(12):1151-4. PubMed ID: 25672733
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).
    Smethurst P; Sidle KC; Hardy J
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):578-97. PubMed ID: 25487060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis.
    Oiwa K; Watanabe S; Onodera K; Iguchi Y; Kinoshita Y; Komine O; Sobue A; Okada Y; Katsuno M; Yamanaka K
    Sci Adv; 2023 Aug; 9(31):eadf6895. PubMed ID: 37540751
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impaired NHEJ repair in amyotrophic lateral sclerosis is associated with TDP-43 mutations.
    Konopka A; Whelan DR; Jamali MS; Perri E; Shahheydari H; Toth RP; Parakh S; Robinson T; Cheong A; Mehta P; Vidal M; Ragagnin AMG; Khizhnyak I; Jagaraj CJ; Galper J; Grima N; Deva A; Shadfar S; Nicholson GA; Yang S; Cutts SM; Horejsi Z; Bell TDM; Walker AK; Blair IP; Atkin JD
    Mol Neurodegener; 2020 Sep; 15(1):51. PubMed ID: 32907630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nuclear poly(ADP-ribose) activity is a therapeutic target in amyotrophic lateral sclerosis.
    McGurk L; Mojsilovic-Petrovic J; Van Deerlin VM; Shorter J; Kalb RG; Lee VM; Trojanowski JQ; Lee EB; Bonini NM
    Acta Neuropathol Commun; 2018 Aug; 6(1):84. PubMed ID: 30157956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis.
    Volkening K; Keller BA; Leystra-Lantz C; Strong MJ
    J Proteome Res; 2018 Apr; 17(4):1712-1729. PubMed ID: 29513014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytoplasmic TDP-43 accumulation drives changes in C-bouton number and size in a mouse model of sporadic Amyotrophic Lateral Sclerosis.
    Bak AN; Djukic S; Kadlecova M; Braunstein TH; Jensen DB; Meehan CF
    Mol Cell Neurosci; 2023 Jun; 125():103840. PubMed ID: 36921783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis.
    Yabata H; Riku Y; Miyahara H; Akagi A; Sone J; Urushitani M; Yoshida M; Iwasaki Y
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
    Cai M; Lee KW; Choi SM; Yang EJ
    Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.